Literature DB >> 2115076

Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis.

H Yoshino1, K Miyashita, N Miyatani, T Ariga, Y Hashimoto, S Tsuji, K Oyanagi, E Ohama, F Ikuta, A Suzuki.   

Abstract

In an autopsy case of galactosialidosis, GM3, GM2, GM1, and GD1a were accumulated in sympathetic and spinal ganglia and grey matter of the spinal cord. Especially, the accumulations of GM3 and GM2 amounted to 41- and 86-fold increases in sympathetic ganglia, respectively, as compared to normal controls. In addition LacCer, GA2 and GA1 were accumulated in sympathetic and spinal ganglia. The accumulations of GM3 and GD1a are considered to be the result of defective lysosomal sialidase activity and the accumulation of GM1, LacCer and GA1 is also considered to be due to decreased beta-galactosidase activity in this disorder. To better understand the possible mechanism of GM2 accumulation, we determined the activity of GM2 synthesizing enzyme (GM3:UDP-GalNAc transferase), as well as hexosaminidase activity, in sympathetic ganglia, but they did not change. Abnormal ganglioside and neutral glycosphingolipid metabolism, as well as sialyloligosaccharide and sialylglycoprotein metabolism, may be involved in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115076     DOI: 10.1016/0022-510x(90)90098-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Galactosialidosis: neuropathological findings in a case of the late-infantile type.

Authors:  K Oyanagi; E Ohama; K Miyashita; H Yoshino; T Miyatake; M Yamazaki; F Ikuta
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

3.  Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain.

Authors:  S Dasgupta; E L Hogan; S S Spicer
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

4.  Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies.

Authors:  K Knowles; J Alroy; M Castagnaro; S S Raghavan; R M Jakowski; G O Freden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation.

Authors:  Ryutaro Kajihara; Tadahiro Numakawa; Haruki Odaka; Yuji Yaginuma; Noemi Fusaki; Toshika Okumiya; Hirokazu Furuya; Seiji Inui; Takumi Era
Journal:  Stem Cell Reports       Date:  2020-04-16       Impact factor: 7.765

Review 6.  Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.

Authors:  Bernadette Breiden; Konrad Sandhoff
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

7.  Structural basis for substrate specificity of mammalian neuraminidases.

Authors:  Victoria Smutova; Amgad Albohy; Xuefang Pan; Elena Korchagina; Taeko Miyagi; Nicolai Bovin; Christopher W Cairo; Alexey V Pshezhetsky
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.